Armando Santoro

发表

Phase II study of pemetrexed and carboplatin plus bevacizumab as first-line therapy in malignant pleural mesothelioma

G. Ceresoli, M. Mencoboni, L. Gianoncelli, 2013, British Journal of Cancer.

Fotemustine as second-line treatment for recurrent or progressive glioblastoma after concomitant and/or adjuvant temozolomide: a phase II trial of Gruppo Italiano Cooperativo di Neuro-Oncologia (GICNO)

R. Labianca, A. Brandes, M. Reni, 2009, Cancer Chemotherapy and Pharmacology.

VP-16 in advanced soft tissue sarcoma: a phase II study of the EORTC soft tissue and bone sarcoma group.

A. Santoro, H. Mouridsen, V. Bramwell, 1987, European journal of cancer & clinical oncology.

Carminomycin vs adriamycin in advanced soft tissue sarcomas: an EORTC randomised phase II study.

J. Mulder, R. Sylvester, A. Santoro, 1983, European journal of cancer & clinical oncology.